Table 1

Projected outcomes for the five treatment programme scenarios by 2020 and by 2030

ScenariosNumber of treatments per year
(2018–2020)
Number of treatments per year
(2021–2030)
Number of treatments from 2018 up to 2020 (millions)Number of treatments from 2018 up to 2030 (millions)Incidence reduction by 2020 compared with 2010 (%)Incidence reduction by 2030 compared with 2010 (%)Number of HCV infections averted by 2020Number of HCV infections averted by 2030Number of treatments per infection averted by 2020Number of treatments per infection averted by 2030Cost per infection averted by 2020 (US$)Cost per infection averted by 2030 (US$)
Baseline scale-up scenario200 0000.600.6027%41%13 403126 22144.74.74336456
Scale-up and sustainability scenario200 000200 0000.602.6027%57%13 403301 25944.78.64336834
Target 80% incidence reduction scenario200 000490 0000.605.5027%80%13 403568 86944.79.74336941
Target 90% incidence reduction scenario200 000599 0000.606.6027%90%13 403675 64044.79.84336951
Elimination scenario200 000670 0000.607.3027%99%13 403750 54744.79.74336941
  • HCV, hepatitis C virus.